跳至主要内容
临床试验/IRCT201105185867N4
IRCT201105185867N4已完成2 期

Evaluation of ondansetron in patients with tinnitus: double blind control clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • The inclusion criteria are:
  • 1) Patients with at least 6 month of tinnitus
  • 2) 18 to 65 year old patients
  • 3) Patients with chief compliant of tinnitus
  • 4) Patients with sensorineural or normal hearing
  • Exclusion criteria:
  • 1) Patients with severe illnesses and end stage diseases including liver, kidney and heart impairments. Patients with severe psychosis, dementia, cancers and those who are pregnant or lactating.
  • 2) Patients with excessive problems and ones with psychiatric problems needing psychiatrist visit or ones who had an important surgery recently.
  • 3) Patients with pulsatile tinnitus
  • 4) Patients with worsening of tinnitus with head and neck movements
  • 5) Patients on tinnitus treatment (including sound therapy, complements, drug...) unless still have tinnitus and have been remained on fix dosage of drug for more than acceptable time of action (for medications about 4 weeks).
  • 6) Patients with cerumen impaction (unless tinnitus remained after cerumen removal)

排除标准

  • 未提供

研究者

相似试验